This is a snippet of the transcript, sign up to read more.
Vials are probably the simplest and easiest of all the devices to produce, primarily because they are just glass with no rubber attached. They are the least complex with one end open and the other closed.
This is a snippet of the transcript, sign up to read more.
Cartridges are a bit more complex for two reasons. Firstly, they have two open ends, both of which need to be accurately formed. Secondly, they are likely to be sold with a flip-off seal or a cap on the thinner end before being shipped to the pharmaceutical company. This means that the compatibility between the rubber, the potential aluminum seal, and the glass needs to be considered.
This is a snippet of the transcript, sign up to read more.
The most complex to produce are the syringes. They have a flange at one end, which has to be manufactured using fire. The other end is sharp, and a needle may need to be glued into it, or a luer lock adapter may be used, where the needle is not attached, but chosen by the doctor. So, in terms of complexity and entry barriers, it goes from vials, to cartridges, and then to syringes.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research